InBC Investment Corp. (InBC), a strategic investment fund created by the Province of British Columbia, has made new investments into companies and venture funds to support entrepreneurs and economic growth in the province.
InBC has invested alongside other investors, committing $4 million into 4AG Robotics (formerly TechBrew Robotics) and $5 million into Clarius Mobile Health Corp.
It has also invested $10 million into Amplitude Ventures Fund II and $10 million into the Pender Technology Inflection Fund II, venture funds supporting B.C.-based companies.
“British Columbia is home to a great number and diverse set of companies at the forefront of innovation and aligned to our triple bottom line investment strategy,” said Leah Nguyen, Chief Investment Officer of InBC.
“These investments we announce today are catalyzing impact across sectors and geographic regions in our province; they’re driving innovation, creating quality, family-supporting jobs and building an economic future for B.C. that is more prosperous, sustainable and inclusive.”
4AG Robotics is an agritech company which develops and builds leading robotics solutions for agriculture producers to grow sustainably. Its harvesting robot is helping mushroom farmers to improve their yields and increase operational efficiencies, while addressing labour challenges and reducing food waste in the sector.
Clarius Mobile Health produces wireless handheld ultrasound scanners enabling healthcare practitioners to manage and perform exams from anywhere. It is improving patient outcomes and accessibility to care with scanners that are affordable, ultra-portable and using artificial intelligence to deliver accurate and high-definition imaging.
InBC has invested into venture funds to increase its investing capacity and the number of investors in the province. These venture funds are committed to investing in B.C.-based companies and specialize in specific sectors to support companies across various stages of growth within their respective industries.
Amplitude Ventures is a venture fund that invests in life sciences and biotechnology companies, bringing healthcare innovations to market to help improve the lives of patients. Its Fund II will invest in earlystage companies in the areas of high value therapies, medical technology, and artificial intelligence and machine learning.
Pender Ventures is a venture fund investing in healthtech and B2B technology startups to drive efficiencies and improve clinical decision-making, patient outcomes and healthcare operations. The Pender Technology Inflection Fund II is focusing on companies at the growth stages between commercialization and scale up.